Knowledge and Attitude About HPV Vaccines
1 other identifier
interventional
200
1 country
1
Brief Summary
The purpose of this study was to analyze the knowledge and attitude about HPV vaccines among Brazilian women after an educative intervention. The knowledge was measured on sexual behavior and HPV infection. The attitude was measured on acceptance of vaccines.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Oct 2006
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2009
CompletedFirst Submitted
Initial submission to the registry
January 5, 2010
CompletedFirst Posted
Study publicly available on registry
January 6, 2010
CompletedJanuary 11, 2010
January 1, 2010
3 years
January 5, 2010
January 8, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incorrect knowledge about HPV vaccines was detected on more than 50% women, however the attitude to accept the HPV vaccine was improved after educative intervention.
2 years
Secondary Outcomes (1)
The acceptance of HPV vaccines by the women was depended on the sponsor by the public heath services
2 years
Study Arms (2)
behavioral
ACTIVE COMPARATORthe women received a folder about HPV infection and vaccines and answered a questionaire about sexual behavior, HPV infection and vaccines.
no intervention
NO INTERVENTIONthe women answered a questionaire about sexual behavior, HPV infection and vaccines
Interventions
folder about HPV infection and vaccines
Eligibility Criteria
You may qualify if:
- healthy women
You may not qualify if:
- previous CIN or cervical cancer treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidade Cidade de São Paulo
São Paulo, São Paulo, 03071-000, Brazil
MeSH Terms
Conditions
Study Officials
- STUDY DIRECTOR
Sylvia MF Brenna, MD, PHD
Universidade Cidade de São Paulo
- STUDY CHAIR
Kari J Sirjanen, MD, PhD
University of Turku
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 5, 2010
First Posted
January 6, 2010
Study Start
October 1, 2006
Primary Completion
October 1, 2009
Study Completion
October 1, 2009
Last Updated
January 11, 2010
Record last verified: 2010-01